Cybin (HELP) Free Cash Flow (2020 - 2026)
Cybin's (HELP) quarterly Free Cash Flow came in at -$37.3 million in Q1 2026, down 153.44% YoY from $69.8 million in Q1 2025, and down 18.14% on a QoQ basis from -$31.6 million in Q4 2025.
Cybin (HELP) Free Cash Flow (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Free Cash Flow data on file, last reported at -$37.3 million in Q1 2026.
- Quarterly Free Cash Flow fell 153.44% year-over-year to -$37.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 81.72% YoY) and the FY2026 annual result came in at -$133.3 million, down 84.26% from the prior year.
- Free Cash Flow fell to -$37.3 million in Q1 2026, from -$31.6 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $5.0 million in Q2 2022 to a low of -$37.3 million in Q1 2026.
- A 5-year average of -$15.9 million and a median of -$15.7 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow surged 32.77% — and 2026, when it plunged 153.44%.
- Tracing HELP's Free Cash Flow over 5 years: stood at -$7.9 million in 2022, then sank by 139.48% to -$19.0 million in 2023, then declined by 1.04% to -$19.2 million in 2024, then plunged by 64.4% to -$31.6 million in 2025, then retreated by 18.14% to -$37.3 million in 2026.
- The last three Free Cash Flow figures came in at -$37.3 million (Q1 2026), -$31.6 million (Q4 2025), and -$34.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | -37.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.29 Mn |
| Mar 31, 2026 | -37.29 Mn |
| Dec 31, 2025 | -31.56 Mn |
| Dec 31, 2025 | -31.56 Mn |
| Sep 30, 2025 | -34.05 Mn |
| Sep 30, 2025 | -34.05 Mn |
| Jun 30, 2025 | -29.32 Mn |
| Jun 30, 2025 | -29.32 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Mar 31, 2025 | -14.71 Mn |
| Dec 31, 2024 | -19.20 Mn |
| Dec 31, 2024 | -19.20 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Sep 30, 2024 | -18.95 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Jun 30, 2024 | -19.90 Mn |
| Mar 31, 2024 | -15.75 Mn |
| Mar 31, 2024 | -15.75 Mn |
| Dec 31, 2023 | -19.00 Mn |
| Dec 31, 2023 | -19.00 Mn |